Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation

Modification of arginine residues by citrullination is catalyzed by peptidylarginine deiminases (PADs), of which five are known, generating irreversible protein structural modifications. We have shown previously that enhanced citrullination of myelin basic protein contributed to destabilization of the myelin membrane in the CNS of multiple sclerosis (MS) patients. We now report increased citrullination of nucleosomal histones by PAD4 in normal-appearing white matter (NAWM) of MS patients and in animal models of demyelination. Histone citrullination was attributable to increased levels and activity of nuclear PAD4. PAD4 translocation into the nucleus was attributable to elevated tumor necrosis factor-α (TNF-α) protein. The elevated TNF-α in MS NAWM was not associated with CD3+ or CD8+ lymphocytes, nor was it associated with CD68+ microglia/macrophages. GFAP, a measure of astrocytosis, was the only cytological marker that was consistently elevated in the MS NAWM, suggesting that TNF-α may have been derived from astrocytes. In cell cultures of mouse and human oligodendroglial cell lines, PAD4 was predominantly cytosolic but TNF-α treatment induced its nuclear translocation. To address the involvement of TNF-α in targeting PAD4 to the nucleus, we found that transgenic mice overexpressing TNF-α also had increased levels of citrullinated histones and elevated nuclear PAD4 before demyelination. In conclusion, high citrullination of histones consequent to PAD4 nuclear translocation is part of the process that leads to irreversible changes in oligodendrocytes and may contribute to apoptosis of oligodendrocytes in MS.

[1]  Aaron J. Johnson,et al.  The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis , 2006, Neurological research.

[2]  S. Ludwin,et al.  The Pathogenesis of Multiple Sclerosis: Relating Human Pathology to Experimental Studies , 2006, Journal of neuropathology and experimental neurology.

[3]  L. Klareskog,et al.  Citrullination is an inflammation-dependent process , 2006, Annals of the rheumatic diseases.

[4]  Y. She,et al.  Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry. , 2005, Biochemistry.

[5]  M. Mehler,et al.  Combinatorial Profiles of Oligodendrocyte-Selective Classes of Transcriptional Regulators Differentially Modulate Myelin Basic Protein Gene Expression , 2005, The Journal of Neuroscience.

[6]  P. Thompson,et al.  Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. , 2005, Biochemistry.

[7]  S. Barnum,et al.  Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis , 2005, The Journal of comparative neurology.

[8]  Anne E Carpenter,et al.  In Vivo HP1 Targeting Causes Large-Scale Chromatin Condensation and Enhanced Histone Lysine Methylation , 2005, Molecular and Cellular Biology.

[9]  P. Casaccia‐Bonnefil,et al.  Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain , 2005, The Journal of cell biology.

[10]  F. Mastronardi,et al.  Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis , 2005, Journal of neuroscience research.

[11]  L. Kinnunen,et al.  NF-κB Is Transported into the Nucleus by Importin α3 and Importin α4* , 2005, Journal of Biological Chemistry.

[12]  G. Scalabrino Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories , 2005, Experimental Neurology.

[13]  R. Denman PAD: the smoking gun behind arginine methylation signaling? , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  L. Klareskog,et al.  Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity , 2005, Arthritis research & therapy.

[15]  W. Bruck,et al.  Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders , 2005, The Journal of Neuroscience.

[16]  W. Brooks Autoimmune disorders result from loss of epigenetic control following chromosome damage. , 2005, Medical hypotheses.

[17]  Steven Clarke,et al.  Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination , 2004, Science.

[18]  Paul Tempst,et al.  Histone Deimination Antagonizes Arginine Methylation , 2004, Cell.

[19]  C. Allis,et al.  Dynamic alterations of specific histone modifications during early murine development , 2004, Journal of Cell Science.

[20]  M. Ameloot,et al.  Cytokine‐induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN‐γ and TNF‐α on apoptosis , 2004 .

[21]  M. Ameloot,et al.  Cytokine‐induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon‐γ and tumor necrosis factor‐α , 2004, Journal of neuroscience research.

[22]  J. Boggs,et al.  Attenuation of Experimental Autoimmune Encephalomyelitis and Nonimmune Demyelination by IFN-β plus Vitamin B12: Treatment to Modify Notch-1/Sonic Hedgehog Balance 1 , 2004, The Journal of Immunology.

[23]  W. V. van Venrooij,et al.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages , 2004, Annals of the rheumatic diseases.

[24]  M. Ameloot,et al.  Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. , 2004, Journal of neuroscience research.

[25]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  O. Vaarala,et al.  Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome , 2003, Scandinavian journal of rheumatology.

[27]  J. Boggs,et al.  The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient , 2003, Multiple sclerosis.

[28]  T. Mimori,et al.  High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis , 2003, Scandinavian journal of rheumatology.

[29]  Yusuke Nakamura,et al.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.

[30]  Yusuke Nakamura,et al.  Functional haplotypes of PADI 4 , encoding citrullinating enzyme peptidylarginine deiminase 4 , are associated with rheumatoid arthritis , 2003 .

[31]  M. Yamada,et al.  Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes* , 2002, The Journal of Biological Chemistry.

[32]  M. Muggironi,et al.  Histone Deacetylase Activity Is Necessary for Oligodendrocyte Lineage Progression , 2002, The Journal of Neuroscience.

[33]  C. Brosnan,et al.  Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation , 2002, Nature Medicine.

[34]  F. Mastronardi,et al.  Peptidylarginine deiminase: a candidate factor in demyelinating disease , 2002, Journal of neurochemistry.

[35]  A. Nicholas,et al.  Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain , 2002, Glia.

[36]  H. Hirano,et al.  Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. , 2002, Biochemical and biophysical research communications.

[37]  D. Reinberg,et al.  Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. , 2001, Genes & development.

[38]  M.,et al.  The Isolation , Characterization , and Lipid-aggregating Properties of a Citrulline Containing Myelin Basic Protein * , 2001 .

[39]  W. Cammer Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro , 2000, Brain Research.

[40]  G. Harauz,et al.  Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. , 2000, Biochemistry.

[41]  S. Kamel‐Reid,et al.  Co‐localization of Patched and activated Sonic hedgehog to lysosomes in neurons , 2000, Neuroreport.

[42]  A. Kawada,et al.  Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. , 2001, European journal of biochemistry.

[43]  T. Senshu,et al.  Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere , 1999, Neuroscience Letters.

[44]  J. Nalbantoglu,et al.  p53 Induction by Tumor Necrosis Factor‐α and Involvement of p53 in Cell Death of Human Oligodendrocytes , 1999, Journal of neurochemistry.

[45]  G. Kollias,et al.  A tumor necrosis factor‐induced model of human primary demyelinating diseases develops in immunodeficient mice , 1999, European journal of immunology.

[46]  G. Kollias,et al.  Transgenic models of TNF induced demyelination. , 1999, Advances in experimental medicine and biology.

[47]  S. Topino,et al.  Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? , 1999, Critical reviews in immunology.

[48]  P. Ye,et al.  Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. , 1999, Endocrinology.

[49]  G. Kollias,et al.  Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. , 1998, The American journal of pathology.

[50]  C. Raine,et al.  Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. , 1998, Revue neurologique.

[51]  H. Okano,et al.  ICE/CED‐3 Family Executes Oligodendrocyte Apoptosis by Tumor Necrosis Factor , 1997, Journal of neurochemistry.

[52]  A. Kawada,et al.  Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat. , 1997, Journal of biochemistry.

[53]  G. Kollias,et al.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.

[54]  C. Allis,et al.  Histone Acetylation and Chromatin Assembly: A Single Escort, Multiple Dances? , 1996, Cell.

[55]  J. Bilbao,et al.  Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein , 1996, Annals of neurology.

[56]  B. Götz,et al.  GLIAL CELL INTERACTIONS WITH TENASCIN-C: ADHESION AND REPULSION TO DIFFERENT TENASCIN-C DOMAINS IS CELL TYPE RELATED , 1996, International Journal of Developmental Neuroscience.

[57]  J. Svaren,et al.  Regulation of gene expression by nucleosomes. , 1996, Current opinion in genetics & development.

[58]  C. Ackerley,et al.  Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. , 1996, The Journal of clinical investigation.

[59]  G. Kollias,et al.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. McLaurin,et al.  A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. , 1995, Journal of neurobiology.

[61]  Jack Antel,et al.  Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro , 1994, Journal of neuropathology and experimental neurology.

[62]  C. Ackerley,et al.  Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.

[63]  C. Ackerley,et al.  Demyelination in a transgenic mouse: A model for multiple sclerosis , 1993, Journal of neuroscience research.

[64]  M. Moscarello,et al.  Deimination of Human Myelin Basic Protein by a Peptidylarginine Deiminase from Bovine Brain , 1993, Journal of neurochemistry.

[65]  H. Takahara,et al.  Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. , 1991, Journal of biochemistry.

[66]  E. Benveniste,et al.  Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.

[67]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[68]  C. Brosnan,et al.  Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.

[69]  S. Tagami,et al.  Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization. , 1989, The Journal of biological chemistry.

[70]  T. Cruz,et al.  Characterization of Myelin Fractions from Human Brain White Matter , 1985, Journal of neurochemistry.

[71]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.